Neuromyelitis optica spectrum disorder – Life with Disease

Go back

Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune condition that attacks the central nervous system, primarily affecting the optic nerves, spinal cord, and sometimes the brain. Living with this condition means facing uncertainty about future attacks, managing physical limitations, and adapting to changes in vision and mobility. Understanding what lies ahead can help patients and families prepare for the journey and make informed decisions about care and support.

Prognosis and What to Expect

The outlook for someone diagnosed with neuromyelitis optica spectrum disorder depends heavily on whether they receive proper treatment to prevent future attacks. Before effective preventive treatments became available, the prognosis was often concerning. Studies showed that approximately 50% of people diagnosed with NMOSD were dependent on a wheelchair or functionally blind within five years of diagnosis[11]. This sobering statistic highlights the serious nature of the condition and the importance of early, aggressive treatment.

The likelihood of recurrence in NMOSD is extremely high, with more than 90% of patients experiencing repeated attacks if left untreated[11]. Within just one year without treatment, 60% of those with NMOSD will experience another attack[4]. Each attack brings the risk of additional damage that may not fully heal, leading to the accumulation of disability over time. Among those who experience optic neuritis (inflammation of the optic nerve that causes vision problems), 67% had partial or no recovery following an attack[14].

After five years with the disease, statistics show that four out of 10 people with NMOSD may be legally blind in at least one eye, and two out of 10 may require a walker for mobility[4]. These numbers reflect the reality of untreated or inadequately treated disease. However, there is reason for hope. With the advent of antibody testing that allows for accurate diagnosis and the development of effective treatments, doctors can now reduce the risk of relapse significantly. Early diagnosis combined with proper preventive therapy has dramatically improved outcomes for many patients.

The pattern of disease in NMOSD is typically relapsing-remitting, meaning that patients experience attacks (also called relapses) that usually last days, followed by periods of recovery that can last weeks, months, or even years[5]. This affects about 90% of patients with NMOSD. Each relapse causes new damage, and over time, these repeated injuries can lead to serious disability. Some people recover well from attacks with treatment, while others experience longer-lasting problems[6].

⚠️ Important
Even one NMOSD attack increases the chance of lasting damage to your nervous system. This is why early diagnosis is crucial. If you experience sudden vision loss, weakness, numbness, or other neurological symptoms, seek medical attention immediately as this could signal a potential medical emergency requiring urgent treatment.

Natural Progression Without Treatment

Without proper preventive treatment, neuromyelitis optica spectrum disorder follows a destructive path. The disease is characterized by unpredictable attacks of inflammation that damage the protective coating around nerves, called myelin[2]. This coating helps electrical signals travel efficiently along nerve fibers, much like insulation around electrical wires. When the immune system mistakenly attacks this protective layer, the nerve signals become disrupted, leading to the various symptoms of NMOSD.

The natural course of untreated NMOSD typically involves repeated attacks that become increasingly problematic. Each attack can cause inflammation in different parts of the central nervous system, most commonly the optic nerves that control vision and the spinal cord that manages movement and sensation in the body[1]. Sometimes the brainstem, which controls basic functions like breathing and swallowing, can also be affected.

During an attack, symptoms can develop over hours or days. Vision may become blurred or lost entirely in one or both eyes. People may experience weakness, numbness, or even paralysis in their arms or legs. Some individuals develop painful muscle spasms, bladder and bowel problems, or experience persistent hiccups, nausea, and vomiting[5]. These symptoms reflect damage occurring in the affected areas of the nervous system.

After an initial attack, some improvement typically occurs as inflammation subsides. However, the recovery is often incomplete, leaving behind residual disability. When the next attack occurs, it may affect the same areas again or involve new regions of the nervous system. With each subsequent attack, the accumulated damage becomes more severe. The disability builds up gradually, like layers, with each relapse adding to the burden of symptoms the person must manage.

The unpredictability of attacks is one of the most challenging aspects of untreated NMOSD. There is no way to know when the next attack will occur, which areas of the nervous system will be affected, or how severe the damage will be. This uncertainty can create significant anxiety and stress for patients and their families. The time between attacks can vary tremendously, from weeks to months or even years, but without preventive treatment, further attacks are almost inevitable.

Possible Complications

Neuromyelitis optica spectrum disorder can lead to numerous complications that extend beyond the primary symptoms of vision loss and mobility problems. These complications arise both from the disease itself and from the disabilities it creates, affecting multiple body systems and aspects of daily functioning.

Vision complications are among the most serious outcomes of NMOSD. Damage to the optic nerves can result in permanent blindness, difficulty seeing colors, problems with depth perception, and sensitivity to glare or halos around lights, especially at night[22]. Some people who initially recover their vision after an attack may experience temporary returns of blurred vision during periods of stress, physical exertion, or heat exposure. The loss or impairment of vision profoundly impacts a person’s ability to work, drive, read, recognize faces, and maintain independence in daily activities.

Spinal cord damage from NMOSD attacks creates problems with bladder and bowel function. When the spinal cord is damaged, two general problems can affect the bladder. The bladder may become overly sensitive and empty too frequently, or it may fail to empty properly, leading to retention of urine[22]. Incomplete bladder emptying increases the risk of urinary tract infections, which are particularly concerning for people taking immunosuppressive medications. Bowel problems, including constipation and loss of control, are also common and can significantly affect quality of life and social participation.

Muscle problems represent another category of complications. Many people with NMOSD develop spasticity, which means their muscles become stiff and tight, sometimes experiencing painful spasms[15]. This stiffness can interfere with movement, make it difficult to perform daily tasks, and cause chronic pain. Conversely, some individuals experience profound weakness or paralysis in their limbs, which may require the use of assistive devices like canes, walkers, or wheelchairs.

Chronic pain is a frequent complication that can take several forms. Some people experience sharp, burning, or shooting nerve pain in their back, neck, arms, or legs[6]. Others develop muscle pain from spasticity or from the strain of moving with weakness. Pain can interfere with sleep, mood, and the ability to participate in activities, creating a cycle where pain leads to reduced activity, which can worsen other symptoms.

Respiratory complications can occur when NMOSD affects the brainstem or the upper spinal cord. Severe attacks in these areas may impair breathing function, potentially requiring mechanical ventilation support. Although less common, these complications can be life-threatening and require intensive medical care.

Sexual dysfunction is an often-overlooked complication that affects both men and women with NMOSD. Spinal cord damage can interfere with the nerve signals necessary for sexual function, leading to erectile dysfunction in men and difficulties with arousal and sensation in both sexes[6]. These issues can strain relationships and affect emotional well-being but are treatable conditions that deserve medical attention.

Secondary complications arise from immobility and reduced activity. People who spend significant time in bed or in a wheelchair face increased risk of pressure sores (also called bedsores or decubitus ulcers), which are wounds that develop when pressure restricts blood flow to the skin. These wounds can become infected and are difficult to heal. Prolonged immobility also increases the risk of blood clots in the legs, which can travel to the lungs and become life-threatening.

Bone health may be compromised in people with NMOSD due to reduced weight-bearing activity and the use of corticosteroid medications for treatment. This can lead to osteoporosis (thinning of the bones) and increased risk of fractures, even from minor trauma.

Impact on Daily Life

Living with neuromyelitis optica spectrum disorder affects virtually every aspect of a person’s daily existence. The physical symptoms, unpredictable nature of attacks, and fear of disability create challenges that extend far beyond medical management, touching on work, relationships, hobbies, independence, and emotional well-being.

Physical limitations from vision loss and mobility problems fundamentally change how people navigate their world. Simple tasks that were once automatic—like reading a book, cooking a meal, driving to the store, or walking to the bathroom—may require adaptation, assistive devices, or help from others. Many people with NMOSD report that low vision forces them to use contrasting colors for room decor and desk organization, rely on large-print books and electronics, and maintain strict organizational systems so they can find things consistently[13]. These adaptations require conscious effort and planning that healthy individuals take for granted.

Mobility challenges may necessitate using canes, walkers, braces, or wheelchairs. People may need to modify their homes by installing railings in showers, ramps at entrances, or widening doorways to accommodate assistive devices[13]. These changes can be expensive and require adjustments from all family members. The loss of driving ability, in particular, dramatically reduces independence and can lead to social isolation.

Work life is significantly impacted by NMOSD. A survey of 98 people with NMOSD across 13 countries revealed that 92% said their disease had affected their mental health and well-being[13]. Many find they cannot continue in their previous careers due to vision loss, fatigue, pain, or mobility limitations. Some must reduce their work hours or transition to different types of employment. The unpredictability of attacks creates anxiety about job security and the ability to meet work responsibilities. Time away for medical appointments, hospitalizations, and recovery periods further complicates maintaining employment.

Fatigue is one of the most commonly reported symptoms affecting daily life in NMOSD, though it often receives less attention than more visible symptoms[15]. This is not ordinary tiredness that resolves with rest. It is a profound exhaustion that can make even basic activities feel overwhelming. Fatigue interferes with the ability to work, socialize, and participate in family activities. People with NMOSD often must carefully budget their limited energy, choosing which activities are most important and accepting that they cannot do everything they once could.

Social relationships undergo strain and transformation. Friends and family members may struggle to understand the invisible aspects of NMOSD, such as fatigue, pain, and cognitive difficulties. The unpredictable nature of the disease makes it hard to commit to social plans, as attacks can occur without warning. Some people with NMOSD report feeling isolated because others in their community have never heard of the condition and cannot relate to their experience. The rarity of NMOSD means most patients do not personally know anyone else with the disease, which can feel lonely.

Hobbies and recreational activities often require modification or abandonment. Vision-dependent activities like reading, crafts, or watching television may become difficult or impossible. Physical hobbies such as sports, hiking, or dancing may no longer be feasible due to mobility limitations or fatigue. Finding new ways to enjoy leisure time that accommodate current abilities becomes an important adaptation strategy.

Emotional and psychological impacts are substantial. Living with uncertainty about when the next attack will occur creates chronic anxiety. Fear of becoming blind or wheelchair-dependent looms over daily life. Some people with NMOSD develop depression or experience grief over the loss of their former life and capabilities. The mental burden of managing a chronic, potentially disabling disease affects self-esteem, confidence, and overall life satisfaction.

⚠️ Important
Mental health support is as important as physical treatment for NMOSD. If you are struggling emotionally, talk to your healthcare provider about connecting with a mental health professional who understands chronic illness. Support groups and counseling can provide valuable coping strategies and help reduce feelings of isolation.

Financial pressures compound these challenges. NMOSD requires expensive medications, frequent medical appointments, diagnostic tests, and hospitalizations for attacks. Even with insurance, copays and out-of-pocket expenses accumulate quickly. Some people need to hire help for tasks like house cleaning, transportation, or personal care. The potential loss of income from reduced work capacity creates additional financial stress. Finding and accessing financial assistance programs becomes a necessary skill for many families affected by NMOSD.

Despite these challenges, many people with NMOSD develop effective coping strategies. Regular exercise, appropriate for their abilities, can boost energy, strengthen muscles, and improve mood, sleep, and pain[13]. Practices like yoga help maintain flexibility and reduce stress. Maintaining social connections, even if activities need modification, protects against isolation. Working with occupational and physical therapists provides practical strategies for maximizing independence. Connecting with others in the NMOSD community through support groups or online forums helps people feel less alone and learn from others’ experiences.

Adapting to life with NMOSD is an ongoing process. What works well one month may need adjustment if the disease progresses or new symptoms develop. Flexibility, patience with oneself, and willingness to accept help from others are valuable attitudes that can improve quality of life. Many people report that while NMOSD has changed their lives significantly, they have found ways to maintain meaning, purpose, and joy despite the limitations imposed by the disease.

Support for Family and Clinical Trial Participation

Family members and loved ones play a crucial role in supporting someone with neuromyelitis optica spectrum disorder, particularly when it comes to navigating the complex landscape of clinical trials and medical care. Understanding how to help effectively requires knowledge about both the disease and the opportunities available through research participation.

Clinical trials represent an important option for people with rare diseases like NMOSD. Because the condition affects relatively few people, clinical research is essential for developing new treatments and improving outcomes. Families should understand that clinical trials serve two purposes: they may provide access to promising new treatments for the person enrolled, and they contribute to scientific knowledge that will help future patients.

When considering clinical trial participation, families can help by researching available studies together with their loved one. Resources for finding NMOSD clinical trials include medical center websites, advocacy organizations focused on rare neuroimmune disorders, and registries maintained by national health institutes. Families can assist by compiling information about trials, including their locations, eligibility requirements, what the study involves, and potential benefits and risks.

Understanding the practical aspects of trial participation helps families provide appropriate support. Clinical trials often require frequent visits to specialized medical centers, which may be far from home. Family members can help with transportation, arranging overnight accommodations when necessary, and managing the logistics of attending appointments. They can accompany their loved one to trial visits, take notes during discussions with research staff, and help track appointments and medication schedules.

Families should understand the concept of informed consent in clinical trials, which means researchers must fully explain the study, including all potential risks and benefits, before someone agrees to participate. Family members can help by asking questions during the consent process, ensuring their loved one understands what participation involves, and supporting their decision whether to enroll or decline. It is important to remember that joining a trial is completely voluntary, and participants can withdraw at any time without penalty.

Financial considerations related to clinical trials matter to families as well. While the experimental treatment and research-related tests are typically provided at no cost, participants may still have expenses for travel, lodging, and time away from work. Some trials offer compensation for these expenses, but not all do. Families can help by researching what costs the trial will cover and planning for out-of-pocket expenses.

Emotional support during trial participation is equally important. The person with NMOSD may experience anxiety about whether they will receive the actual treatment or a placebo (an inactive substance used for comparison). They may worry about side effects or feel disappointed if the treatment does not work as hoped. Family members provide invaluable support by listening to these concerns, offering reassurance, and maintaining perspective throughout the trial process.

Beyond clinical trials, families support their loved ones in many other ways. Education about NMOSD helps family members understand what their loved one is experiencing. Learning about symptoms, treatments, prognosis, and daily challenges enables more effective support. Many resources are available, including information from advocacy organizations, medical websites, and support groups specifically for family members and caregivers.

Practical assistance makes a significant difference in daily life. Family members might help with tasks that have become difficult due to vision loss or mobility limitations—things like grocery shopping, meal preparation, house cleaning, transportation, or assistance with personal care. Offering help in specific, concrete ways (“I can drive you to your appointment Tuesday” or “I’ll bring dinner on Wednesday”) is often more useful than general offers of help.

Communication within families requires attention and care. The person with NMOSD may struggle to explain their experience, particularly invisible symptoms like fatigue, pain, or cognitive difficulties. Family members can create opportunities for open conversation by asking specific questions and listening without judgment. It is important to balance showing concern with respecting the person’s autonomy and desire to maintain independence as much as possible.

Family members caring for someone with NMOSD should also attend to their own needs. Caregiver stress and burnout are real risks, particularly as the disease progresses or after a severe attack. Taking breaks, pursuing personal interests, seeking support from others in similar situations, and sometimes getting professional counseling for themselves helps family members sustain their support over the long term. Support groups specifically for family members and caregivers of people with rare neuroimmune disorders provide valuable connection and practical advice.

Helping with medical advocacy is another important family role. Family members can accompany their loved one to medical appointments, help prepare questions for doctors, take notes during visits, and help ensure that healthcare providers understand the full scope of symptoms and concerns. When hospitalization for an NMOSD attack is necessary, having a family member present to communicate with medical staff and advocate for appropriate care can be enormously helpful.

Preparing for emergencies together provides peace of mind for everyone. Families should know the warning signs of an NMOSD attack (sudden vision changes, weakness, numbness, severe vomiting and hiccups) and understand that these require immediate medical attention. Having a plan for how to respond to an attack—knowing which hospital to go to, having medical information readily available, and understanding the person’s treatment preferences—helps families act quickly and effectively when needed.

Financial planning and practical matters benefit from family involvement. Helping to research disability benefits, insurance coverage, financial assistance programs, and community resources reduces the burden on the person with NMOSD. Families might assist with paperwork, making phone calls to insurance companies, or navigating complex medical billing issues.

Ultimately, the most valuable support families provide may simply be their presence and commitment. Knowing that loved ones will stand by them through uncertain times, celebrate improvements, and help manage setbacks provides emotional security that enhances resilience and coping. The journey with NMOSD is challenging, but families who educate themselves, communicate openly, and access available resources can make that journey more manageable for everyone involved.

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Eculizumab – An approved preventive immunotherapy for AQP4-IgG positive NMOSD that targets specific immune pathways to reduce the risk of attacks.
  • Ravulizumab – A recently approved preventive immunotherapy for AQP4-IgG positive NMOSD, similar in mechanism to eculizumab, used to prevent relapses.
  • Inebilizumab – An approved preventive treatment specifically for AQP4-IgG positive NMOSD that works by targeting immune cells to reduce attack frequency.
  • Satralizumab – An approved immunotherapy for NMOSD that blocks specific immune signaling pathways involved in inflammation and can be used alone or with other immunosuppressive therapies.
  • Rituximab – An established treatment option used off-label in the United States to prevent relapses in both AQP4-IgG positive and negative NMOSD.
  • Mycophenolate mofetil (CellCept) – An immunosuppressive medication used off-label as one of the primary long-term preventive therapies for NMOSD.
  • Azathioprine (Imuran) – An immunosuppressive drug used off-label for long-term prevention of attacks in NMOSD patients.

Ongoing Clinical Trials on Neuromyelitis optica spectrum disorder

  • Study of Satralizumab for Children with Neuromyelitis Optica Spectrum Disorder (NMOSD)

    Recruiting

    1 1 1
    Investigated drugs:
    France Italy Poland
  • Study on Imlifidase for Treating Acute Inflammation in Patients with Neuromyelitis Optica Spectrum Disorder

    Recruiting

    1 1 1
    Investigated drugs:
    The Netherlands
  • Study on the Effectiveness and Safety of Ravulizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder (NMOSD)

    Recruiting

    1 1 1 1
    Investigated drugs:
    France Italy Spain
  • Study of Inebilizumab for Children and Adolescents with Neuromyelitis Optica Spectrum Disorder

    Recruiting

    1 1 1
    Investigated drugs:
    France The Netherlands Poland Spain Sweden

References

https://www.mayoclinic.org/diseases-conditions/neuromyelitis-optica/symptoms-causes/syc-20375652

https://my.clevelandclinic.org/health/diseases/9858-neuromyelitis-optica-nmo

https://www.ncbi.nlm.nih.gov/books/NBK572108/

https://www.nmosdwontstopme.com/what-is-nmosd

https://www.ohsu.edu/brain-institute/neuromyelitis-optica-spectrum-disorder-nmosd

https://www.nhs.uk/conditions/neuromyelitis-optica/

https://link.springer.com/article/10.1007/s00415-023-11910-z

https://www.mayoclinic.org/diseases-conditions/neuromyelitis-optica/diagnosis-treatment/drc-20375655

https://pmc.ncbi.nlm.nih.gov/articles/PMC6172906/

https://my.clevelandclinic.org/health/diseases/9858-neuromyelitis-optica-nmo

https://wearesrna.org/living-with-myelitis/disease-information/neuromyelitis-optica-spectrum-disorder/prognosis-management/

https://pmc.ncbi.nlm.nih.gov/articles/PMC8395403/

https://nmosd.com/nmosd-support/living-with-nmosd

https://www.nmosdwontstopme.com/resources/life-with-nmosd

https://www.webmd.com/eye-health/neuromyelitis-optica-life-with

https://www.roche.com/stories/living-with-nmosd-advice-from-a-working-mother

https://neuromyelitis-optica.net/living-with

https://www.enspryng.com/real-patient-stories.html

https://www.gene.com/stories/living-well-with-nmosd

https://unifyrare.com/en/nmosd/living-nmosd

https://www.nmosdwontstopme.com/

https://wearesrna.org/living-with-myelitis/disease-information/neuromyelitis-optica-spectrum-disorder/long-term-care/

FAQ

Is NMOSD hereditary? Will I pass it to my children?

NMOSD is not usually inherited. Only about 3 in every 100 people with NMOSD have a relative with the condition. While it occurs more commonly in families with NMOSD than in the general population, the vast majority of cases are not passed from parent to child. If you’re considering having children, discuss your specific situation with your doctor.

How is NMOSD different from multiple sclerosis?

While NMOSD and MS share some similar symptoms, they are distinct diseases. NMOSD typically has more severe attacks that can cause disability from a single episode, whereas MS usually requires multiple attacks over time to cause similar disability. NMOSD often affects both eyes simultaneously, while MS typically affects one eye at a time. Importantly, the blood test for AQP4 antibodies is positive in NMOSD and negative in MS. The treatments are also different, making correct diagnosis essential.

Can I still work with NMOSD?

Many people with NMOSD continue working, though some need to make adjustments. Depending on your symptoms and the severity of your attacks, you might reduce your hours, change job roles, or require workplace accommodations. Vision loss and mobility limitations can affect certain types of work more than others. With preventive treatment to reduce attacks and appropriate support, many individuals maintain employment successfully.

Will I definitely go blind or need a wheelchair?

Not necessarily. While those statistics reflected outcomes before modern treatments became available, early diagnosis and proper preventive treatment have dramatically improved prognosis. The high rates of blindness and wheelchair dependence occurred mainly in people who went untreated or were misdiagnosed. With today’s approved therapies that reduce attack risk, many people with NMOSD avoid these severe outcomes. Each person’s course is different, but proper treatment offers significant hope.

How do I know if I’m having an NMOSD attack that needs immediate medical attention?

Warning signs of an NMOSD attack include sudden vision changes or loss in one or both eyes, new or worsening weakness or numbness in your limbs, severe or persistent hiccups combined with nausea and vomiting, and sudden problems with bladder or bowel control. If you experience any of these symptoms, seek medical care immediately, as prompt treatment during an attack is crucial to prevent permanent damage.

🎯 Key takeaways

  • Without preventive treatment, more than 90% of NMOSD patients will experience repeated attacks, but modern therapies can dramatically reduce this risk.
  • Within five years without treatment, 4 out of 10 people may become legally blind in at least one eye, and 2 out of 10 may need a walker—making early treatment critical.
  • NMOSD is not a type of multiple sclerosis despite sharing similar symptoms; it requires completely different treatments, and some MS medications can worsen NMOSD.
  • A simple blood test for AQP4-IgG antibodies can confirm NMOSD diagnosis and distinguish it from MS, making accurate testing essential before starting treatment.
  • Four new preventive therapies have been approved specifically for NMOSD in recent years, offering hope for better outcomes than were previously possible.
  • Women are affected by NMOSD 4 to 10 times more often than men, with the condition typically appearing between ages 30 and 40.
  • Approximately 92% of people with NMOSD report that the disease has impacted their mental health, highlighting the importance of psychological support alongside physical treatment.
  • NMOSD is extremely rare, affecting only between 0.3 and 4.4 people per 100,000, meaning most patients won’t personally know anyone else with the condition.